SCHEMBL7779625

SCHEMBL7779625

Cc1ccc(-c2c(-c3ccc(S(N)(=O)=O)cc3)nn(Cc3ccccc3)c2CO)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.51
CA2 P00918 10/20 0.47
CA9 Q16790 10/20 0.47
CA1 P00915 9/20 0.47
CA4 P22748 2/20 0.44
CYP2C9 P11712 1/20 0.44
CA12 O43570 4/20 0.44
PTGS1 P23219 3/20 0.44
MT-CO2 P00403 1/20 0.44
LMNA P02545 1/20 0.44
CA3 P07451 1/20 0.44
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
ADRA2B P18089 1/20 0.44
CA6 P23280 1/20 0.44
SLC6A2 P23975 1/20 0.44
PDE4A P27815 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777321 0.90 PTGS2 (0.47) PTGS2CA2CA9CA1CA4
SCHEMBL7779319 0.90 PTGS2 (0.62) PTGS2PTGS1SMN1; SMN2
SCHEMBL7772814 0.90 PTGS2 (0.48) PTGS2CA2CA9CA1CA4
SCHEMBL7779844 0.88 PTGS2 (0.53) PTGS2CA2CA9CA1CA4
SCHEMBL7779927 0.87 PTGS2 (0.48) PTGS2CA2CA9CA1CA4
SCHEMBL7779903 0.85 PTGS2 (0.55) PTGS2CA2CA9CA1CA4
SCHEMBL8634661 0.85 PTGS2 (0.45) PTGS2CYP2C9PTGS1CYP3A4SMN1; SMN2
SCHEMBL7773087 0.85 PTGS2 (0.48) PTGS2CA2CA9CA1CA4
SCHEMBL7779503 0.82 PTGS2 (0.48) PTGS2CA2CA9CA1CA4
SCHEMBL7778076 0.82 PTGS2 (0.48) PTGS2CA2CA9CA1CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed